Monashee Investment Management »

Veradermics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Veradermics shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Veradermics

Tip: Access up to 7 years of quarterly data

All positions including Veradermics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veradermics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 50k 63.15

More positions owned by Monashee Investment Management

Terns Pharmaceuticals (TERN)
Nextera Energy Unit 02/15/2029 (NEE.PV)
Medline Com Cl A (MDLN)
Nrg Energy Com New (NRG)
Forgent Power Solutions Com Shs Cl A (FPS)
Solid Biosciences Com New (SLDB)
Nektar Therapeutics Com New (NKTR)
Cytokinetics Com New (CYTK)
Joby Aviation Note 0.750% 2/1
Ppl Corp Unit 02/15/2029
Bridgebio Pharma (BBIO)
Adt (ADT)
Oracle Corp 6.5 Dep Cum Sr D (ORCL.PD)
Evommune Com Shs (EVMN)
Kkr & Co 6.25 Con Ser D (KKR.PD)

View all positions for Monashee Investment Management

Top funds holding Veradermics

Suvretta Capital Management
Citadel Advisors
Viking Global Investors
Standard Life Aberdeen
Infinitum Asset Management
Vanguard Capital Management
Balyasny Asset Management
Paradigm Biocapital Advisors
Ameriprise Financial
Woodline Partners
Deep Track Capital
UBS Group
Vivo Capital
Stifel Financial
BlackRock

View all funds holding Veradermics